BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 32246472)

  • 1. Locoregional recurrences after transanal total mesorectal excision of rectal cancer during implementation.
    van Oostendorp SE; Belgers HJ; Bootsma BT; Hol JC; Belt EJTH; Bleeker W; Den Boer FC; Demirkiran A; Dunker MS; Fabry HFJ; Graaf EJR; Knol JJ; Oosterling SJ; Slooter GD; Sonneveld DJA; Talsma AK; Van Westreenen HL; Kusters M; Hompes R; Bonjer HJ; Sietses C; Tuynman JB
    Br J Surg; 2020 Aug; 107(9):1211-1220. PubMed ID: 32246472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structured training pathway and proctoring; multicenter results of the implementation of transanal total mesorectal excision (TaTME) in the Netherlands.
    Veltcamp Helbach M; van Oostendorp SE; Koedam TWA; Knol JJ; Stockmann HBAC; Oosterling SJ; Vuylsteke RCLM; de Graaf EJR; Doornebosch PG; Hompes R; Bonjer HJ; Sietses C; Tuynman JB
    Surg Endosc; 2020 Jan; 34(1):192-201. PubMed ID: 30888498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The learning curve of transanal total mesorectal excision for rectal cancer is associated with local recurrence: results from a multicentre external audit.
    Van Oostendorp SE; Belgers HJE; Hol JC; Doornebosch PG; Belt EJT; Oosterling SJ; Kusters M; Bonjer HJJ; Sietses C; Tuynman JB
    Colorectal Dis; 2021 Aug; 23(8):2020-2029. PubMed ID: 33969621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transanal mesorectal excision: early outcomes in Australia and New Zealand.
    Lau S; Kong J; Bell S; Heriot A; Stevenson A; Moloney J; Hayes J; Merrie A; Eglinton T; Guest G; Clark D; Warrier S
    Br J Surg; 2021 Mar; 108(2):214-219. PubMed ID: 33711138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transanal versus conventional total mesorectal excision for rectal cancer using the IDEAL framework for implementation.
    Robertson RL; Karimuddin A; Phang T; Raval M; Brown C
    BJS Open; 2021 Mar; 5(2):. PubMed ID: 33889949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review and meta-analysis of oncological outcomes with transanal total mesorectal excision for rectal cancer.
    Neary E; Ibrahim T; Verschoor CP; Zhang L; Patel SV; Chadi SA; Caycedo-Marulanda A
    Colorectal Dis; 2024 May; 26(5):837-850. PubMed ID: 38590019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of a Single Surgeon-Based Transanal-Total Mesorectal Excision (TATME) for Rectal Cancer.
    Caycedo-Marulanda A; Jiang HY; Kohtakangas EL
    J Gastrointest Cancer; 2018 Dec; 49(4):455-462. PubMed ID: 28702861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transanal total mesorectal excision for rectal cancer has been suspended in Norway.
    Wasmuth HH; Faerden AE; Myklebust TÅ; Pfeffer F; Norderval S; Riis R; Olsen OC; Lambrecht JR; Kørner H; Larsen SG; ; Forsmo HM; Baekkelund O; Lavik S; Knapp JC; Sjo O; Rashid G
    Br J Surg; 2020 Jan; 107(1):121-130. PubMed ID: 31802481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is trans-anal total mesorectal excision really safe and better than laparoscopic total mesorectal excision with a perineal approach first in patients with low rectal cancer? A learning curve with case-matched study in 68 patients.
    Mege D; Hain E; Lakkis Z; Maggiori L; Prost À la Denise J; Panis Y
    Colorectal Dis; 2018 Jun; 20(6):O143-O151. PubMed ID: 29693307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transanal total mesorectal excision (TaTME) versus laparoscopic TME for MRI-defined low rectal cancer: a propensity score-matched analysis of oncological outcomes.
    Roodbeen SX; Penna M; Mackenzie H; Kusters M; Slater A; Jones OM; Lindsey I; Guy RJ; Cunningham C; Hompes R
    Surg Endosc; 2019 Aug; 33(8):2459-2467. PubMed ID: 30350103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An international multicentre prospective audit of elective rectal cancer surgery; operative approach versus outcome, including transanal total mesorectal excision (TaTME).
    2017 European Society of Coloproctology (ESCP) collaborating group
    Colorectal Dis; 2018 Sep; 20 Suppl 6():33-46. PubMed ID: 30255642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical, Clinical, Methodological Evaluation of Local Recurrence Following Transanal Total Mesorectal Excision for Rectal Cancer: A Systematic Review.
    Wasmuth HH; Gachabayov M; Bokey L; Fingerhut A; Orangio GR; Remzi FH; Bergamaschi R
    Dis Colon Rectum; 2021 Jul; 64(7):899-914. PubMed ID: 33938532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-year outcome after transanal versus laparoscopic total mesorectal excision in locally advanced rectal cancer: a multicenter comparative analysis.
    de Lacy FB; Roodbeen SX; Ríos J; van Laarhoven J; Otero-Piñeiro A; Bravo R; Visser T; van Poppel R; Valverde S; Hompes R; Sietses C; Castells A; Bemelman WA; Tanis PJ; Lacy AM
    BMC Cancer; 2020 Jul; 20(1):677. PubMed ID: 32689968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term outcomes after transanal total mesorectal excision for rectal cancer in Denmark - a prospective multicentre study.
    Klein MF; Seiersen M; Bulut O; Bech-Knudsen F; Jansen JE; Gögenur I
    Colorectal Dis; 2021 Apr; 23(4):834-842. PubMed ID: 33226722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transanal total mesorectal excision: 3-year oncological outcomes.
    Ourô S; Albergaria D; Ferreira MP; Costeira B; Roquete P; Ferreira D; Maio R
    Tech Coloproctol; 2021 Feb; 25(2):205-213. PubMed ID: 33113009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transanal total mesorectal excision (taTME) for rectal cancer: a training pathway.
    McLemore EC; Harnsberger CR; Broderick RC; Leland H; Sylla P; Coker AM; Fuchs HF; Jacobsen GR; Sandler B; Attaluri V; Tsay AT; Wexner SD; Talamini MA; Horgan S
    Surg Endosc; 2016 Sep; 30(9):4130-5. PubMed ID: 26659246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transanal total mesorectal excision for rectal cancer: early outcomes in 50 consecutive patients.
    Burke JP; Martin-Perez B; Khan A; Nassif G; de Beche-Adams T; Larach SW; Albert MR; Atallah S
    Colorectal Dis; 2016 Jun; 18(6):570-7. PubMed ID: 26749148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term oncological results after transanal total mesorectal excision for rectal carcinoma.
    Hol JC; van Oostendorp SE; Tuynman JB; Sietses C
    Tech Coloproctol; 2019 Sep; 23(9):903-911. PubMed ID: 31599385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes and case volume effect of transanal total mesorectal excision for rectal cancer: a systematic review.
    Deijen CL; Tsai A; Koedam TW; Veltcamp Helbach M; Sietses C; Lacy AM; Bonjer HJ; Tuynman JB
    Tech Coloproctol; 2016 Dec; 20(12):811-824. PubMed ID: 27853973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes after transanal total mesorectal excision for rectal cancer in Denmark: A prospective multicenter study from the late implementation phase.
    Rehné Jensen L; Dohrn N; Seiersen M; Bulut O; Bech-Knudsen F; Erik Jansen J; Gögenur I; Falk Klein M
    Surg Oncol; 2023 Aug; 49():101967. PubMed ID: 37356316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.